Article Information
History
- July 28, 2021.
Article Versions
- Version 1 (July 21, 2021 - 20:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- John B. G. Mackey1,3,*,
- Amanda J. McFarlane1,
- Thomas Jamieson1,
- Rene Jackstadt1,4,
- Ximena L. Raffo-Iraolagoitia1,
- Judith Secklehner1,3,
- Xabier Cortes-Lavaud1,
- Frédéric Fercoq1,
- William Clarke1,
- Ann Hedley1,
- Kathryn Gilroy1,
- Sergio Lilla1,
- Juho Vuononvirta3,5,
- Gerard J. Graham6,
- Katia De Filippo3,
- Daniel J. Murphy1,2,
- Colin W. Steele1,2,
- Jim C. Norman1,2,
- Thomas G. Bird1,7,
- Derek A. Mann8,
- Jennifer P. Morton1,2,
- Sara Zanivan1,2,
- Owen J. Sansom1,2 and
- Leo M. Carlin1,2,3,*
- 1Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK
- 2Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK
- 3Inflammation, Repair & Development, Imperial College London, London, UK
- 4HI-STEM, Heidelberg, Germany
- 5William Harvey Research Institute, London, UK.
- 6Chemokine Research Group, University of Glasgow, Glasgow, UK.
- 7MRC Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, EH16 4TJ, UK
- 8Newcastle Fibrosis Research Group, Bioscience Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, UK
- ↵*Correspondence Leo M. Carlin, Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, United Kingdom, G61 1BD Email: leo.carlin{at}glasgow.ac.uk